Observations by a European Venture Capitalist
So you’ve got a brilliant idea, a scrappy founding team, maybe even a pilot in motion—and now you need capital. Not just any capital. Smart capital. The kind that understands HIPAA, clinical trials, and why your sales cycle is longer than a B2B SaaS tool.
Welcome to the world of digital health VCs.
This is not a generic list of …
Ever wonder what actually happens after you walk out of a pitch meeting? Here’s a hint: the real decision-making happens after you leave the room.
Digital health VCs are a specific breed. They’re not just asking, “Is this exciting?” They’re weighing risk like clinicians, evaluating business models like payers, and checking traction like SaaS pros. The decision to invest—or pass—is …
For many digital health startups, the journey begins with a napkin sketch, a prototype duct-taped together in a co-working space, and a dream of disrupting the medical-industrial complex. But breaking into healthcare isn’t like building a food delivery app. It’s a heavily regulated, risk-averse system that doesn’t hand out warm intros or pilot programs to anyone with a pitch deck …
If your pitch was compelling enough to spark VC interest, congrats—you’ve entered the due diligence zone. Now comes the real test: your data room.
The data room is where startups win or lose deals behind the scenes. It’s not just a Dropbox folder with pitch decks. It’s your startup’s story, risk profile, and roadmap—all packaged in a way that investors …
A pitch deck is more than a formality in digital health—it’s your first real diagnostic test. If investors can’t quickly grasp what you’re building, how it fits into the ecosystem, and why your team is qualified to pull it off, they’ll mentally swipe left in 90 seconds or less.
Worse, if you miss the critical healthcare-specific elements (think regulation, reimbursement, …
Venture capital plays a crucial role in scaling digital health innovations from promising prototypes to market-ready solutions. In recent years the flow of investment into telemedicine platforms, remote monitoring devices and AI-driven diagnostic tools has enabled entrepreneurs to build products that can be deployed across healthcare systems.
Investors are looking beyond flashy technology to businesses that can navigate regulatory pathways, …
Getting a VC meeting is one thing. Getting the right VC to take you seriously, lean forward, and eventually wire money? Entirely different ballgame.
Too many digital health founders get stuck in the spray-and-pray stage—blasting cold emails to generic investor lists, hoping something sticks. But smart founders treat VC selection the same way good VCs treat startups: they research hard, …
Your pitch deck isn’t just a PDF—it’s a filter. A litmus test. A silent first impression that determines whether an investor hits delete or leans in.
Digital health founders often get this wrong. Either it’s a glorified product demo with no business model, or it’s a 40-slide manifesto that reads like a regulatory policy doc.
In a space where both …
In digital health, product-market fit means nothing if you can’t navigate the minefield of payers, providers, and regulations. Your idea might be revolutionary—but if your go-to-market (GTM) plan sounds like “we’ll sell to hospitals,” you’re not getting funded.
A killer GTM isn’t just a slide in your deck. It’s your blueprint for survival.
This guide breaks down how digital health …
The year has kicked off on a strong note for digital health. We’ve already seen $1.8 billion flow into the space, and that’s just the beginning.
Looking at 2016 and into 2018, I’m expecting a continued rise in Series A-stage companies. What’s exciting is that many of …